A new class of agents for estrogen-receptor-positive breast cancer

Expert Rev Clin Pharmacol. 2018 Apr;11(4):325-328. doi: 10.1080/17512433.2018.1439736.

Authors

Dede N Ekoue^{1

2}, Nisha Unni³, Ganesh V Raj^{1

2}

Affiliations

¹ a Department of Urology , University of Texas Southwestern Medical Center , Dallas , TX , USA.
² b Department of Pharmacology , University of Texas Southwestern Medical Center , Dallas , TX , USA.
³ c Department of Medical Oncology , University of Texas Southwestern Medical Center , Dallas , TX , USA.

PMID: 29439601
DOI: 10.1080/17512433.2018.1439736

No abstract available

Keywords: Estrogen receptor; breast cancer; coregulator modulator; estrogen receptor coregulators; therapy resistance.

Publication types

Editorial

MeSH terms

Antineoplastic Agents, Hormonal / administration & dosage
Antineoplastic Agents, Hormonal / pharmacology*
Breast Neoplasms / drug therapy*
Breast Neoplasms / pathology
Drug Design
Estrogen Receptor alpha / metabolism*
Female
Humans

Substances

Antineoplastic Agents, Hormonal
Estrogen Receptor alpha